日本慢性阻塞性肺病患者的支气管切除症:一项前性队列研究
Seiichi Kobayashi1, Mitsuhiro Yamada2, Masatsugu Ishida1
1Department of Respiratory Medicine, Japanese Red Cross Ishinomaki Hospital, 71 Nishimichishita, Hebita, Ishinomaki, Miyagi, 986-8522, Japan.
Respiratory investigation
|July 31, 2025
概括
在日本慢性阻塞性肺病 (COPD) 患者中,支气管切除症在五年内没有恶化临床结果. 然而,COPD患者的死亡率与支气管切除与疾病严重程度和 Pseudomonas aeruginosa 感染有关.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床流行病学 临床流行病学
背景情况:
- 支气管切除症经常与慢性阻塞性肺病 (COPD) 一起发生,往往导致较差的结果.
- 关于日本COPD患者中支气管切除症的患病率和影响的数据有限.
- 这项研究解决了在这个特定的人群中了解支气管切除症的差距.
研究的目的:
- 为了确定日本COPD患者中支气管切除症的患病率.
- 为了描述COPD患者的临床特征,有和没有支气管切除.
- 评估支气管切除症对临床结果的影响,包括恶化和死亡率,在5年的随访期内.
主要方法:
- 一项前性观察性研究招募了302名患有稳定性COPD的日本患者.
- 收集的数据包括患者特征,恶化频率和死亡率.
- 考克斯的比例危险模型被用来评估支气管切除和死亡率之间的关联.
主要成果:
- 在被录取的COPD患者中,有15%患有放射性支气管病变.
- 患有COPD和支气管切除症的患者年龄较大,病期较长.
- 在5年内,在各组之间没有观察到恶化或死亡率的显著差异.
结论:
- 放射性支气管切除与日本COPD患者在5年时间内没有不良临床结果相关.
- 在COPD患者中,死亡风险因素包括气流阻塞,呼吸不全,较差的健康状况,较高的支气管切除重度指数和阳性Pseudomonas aeruginosa培养物.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


